Table 2. ROC Analysis of CSF Aβs for Distinguishing Abnormal From Normal Visual Reading Assessments of Flutemetamol F 18–Labeled PET.
Immunoassaya | AUC (95% CI) | Cutoff (Cutoff for Mixture Modeling Analysis)b | Youden J Index | Sensitivity | Specificity |
---|---|---|---|---|---|
Classic Aβ42-INNOTEST | 0.92 (0.89-0.95) | ≤548.00 (524.00) | 0.78 | 0.96 | 0.82 |
Classic INNOTEST Aβ42:Aβ40 ratio | 0.92 (0.88-0.95) | ≤0.06 (0.05) | 0.73 | 0.91 | 0.82 |
Classic INNOTEST Aβ42:T-tau ratio | 0.94 (0.91-0.97)c | ≤1.79 (1.23) | 0.84 | 0.96 | 0.87 |
Classic INNOTEST Aβ42:P-tau ratio | 0.95 (0.92-0.98)c,d | ≤10.30 (8.11) | 0.83 | 0.95 | 0.89 |
Modified Aβ42-INNOTEST | 0.87 (0.83-0.91)e | ≤1091.00 (1129.00) | 0.67 | 0.92 | 0.74 |
Modified INNOTEST Aβ42:Aβ40 ratio | 0.93 (0.90-0.96)f | ≤0.12 (0.10) | 0.79 | 0.92 | 0.87 |
Modified INNOTEST Aβ42:T-tau ratio | 0.94 (0.91-0.97)g | ≤3.30 (2.38) | 0.83 | 0.96 | 0.88 |
Modified INNOTEST Aβ42:P-tau ratio | 0.95 (0.92-0.97)g | ≤19.60 (16.50) | 0.82 | 0.95 | 0.87 |
Aβ42-EI | 0.88 (0.84-0.92)e | ≤449.00 (479.00) | 0.63 | 0.82 | 0.80 |
Aβ42-EI:Aβ40 ratio | 0.93 (0.90-0.96)h | ≤0.10 (0.10) | 0.81 | 0.93 | 0.88 |
Aβ42-EI:T-tau ratio | 0.94 (0.90-0.97)h | ≤1.44 (1.11) | 0.81 | 0.96 | 0.86 |
Aβ42-EI:P-tau ratio | 0.94 (0.91-0.96)i | ≤9.59 (7.26) | 0.81 | 0.95 | 0.87 |
Aβ42-MSD | 0.89 (0.85-0.93)j | ≤506.00 (500.00) | 0.70 | 0.94 | 0.76 |
Aβ42-MSD:Aβ40 ratio | 0.95 (0.93-0.98)k | ≤0.08 (0.09) | 0.86 | 0.96 | 0.89 |
Aβ42-MSD:T-tau ratio | 0.94 (0.91-0.97)l | ≤1.39 (1.12) | 0.85 | 0.96 | 0.89 |
Aβ42-MSD:P-tau ratio | 0.95 (0.92-0.98)k | ≤9.89 (7.84) | 0.83 | 0.96 | 0.87 |
Abbreviations: Aβ, amyloid β; AUC, area under the curve; CSF, cerebrospinal fluid; EI, EUROIMMUN; MSD, Meso Scale Discovery; PET, positron emission tomography; P-tau, phosphorylated tau; ROC, receiver operating characteristic; T-tau, total tau.
Cerebrospinal fluid levels of T-tau and P-tau were quantified with EUROIMMUN and INNOTEST enzyme-linked immunosorbent assay kits, respectively. These tau values and Aβ42 values from the 5 different assays (classic and modified INNOTESTs, fully automated Lumipulse, EI, and MSD) were used for the calculations of the CSF Aβ42:tau ratios.
Cutoffs for Aβ42 are given in pg/mL.
P ≤ .01 compared with classic INNOTEST Aβ42:Aβ40 ratio.
P ≤ .05 compared with classic Aβ42-INNOTEST level.
P ≤ .001 compared with classic Aβ42-INNOTEST level.
P ≤ .01 compared with modified Aβ42-INNOTEST level.
P ≤ .001 compared with modified Aβ42-INNOTEST level.
P ≤ .01 compared with Aβ42-EI level.
P ≤ .001 compared with Aβ42-EI level.
P ≤ .01 compared with classic Aβ42-INNOTEST level.
P ≤ .001 compared with Aβ42-MSD level.
P ≤ .05 compared with Aβ42-MSD level.